Other Effects of Fluvastatin Are Investigated in Patients With Metabolic Syndrome
Other effects of fluvastatin are investigated in German patients with metabolic syndrome...
Brief Summary
Official Title: “Other Effects of Fluvastatin Are Investigated in Patients With Metabolic Syndrome”
Other effects of fluvastatin are investigated in German patients with metabolic syndrome.
- Study Type: Interventional
- Study Design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double-Blind, Primary Purpose: Treatment
- Study Primary Completion Date: February 2006
Intervention(s) in this Clinical Trial
- Drug: Fluvastatin
Outcome Measures for this Clinical Trial
Primary Measures
- Change from baseline in circulating marker of inflammation (C-reactive protein) after 5 weeks
Secondary Measures
- Change from baseline in low density lipoprotein cholesterol after 5 weeks
- Change from baseline in non high density lipoprotein cholesterol after 5 weeks
- Change from baseline in total cholesterol after 5 weeks
- Change from baseline in high density lipoprotein cholesterol after 5 weeks
- Change from baseline in oxidized low density lipoprotein cholesterol after 5 weeks
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Written informed consent
- Male and female patients, aged between 18 and 75 years
- Metabolic syndrome according to National Cholesterol Education Program Adult
- Treatment Panel III (NCEP ATPIII)
Exclusion Criteria:
- History of heart failure
- HIV positive
- Stroke
- Other protocol defined inclusion and exclusion criteria may apply.
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: 75 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Investigator Information
Lead Investigator: Novartis Industry
Overall Clinical Trial Officials and Contacts
Novartis Pharmaceuticals Study Director Novartis Pharmaceuticals
Additional Information
Information obtained from ClinicalTrials.gov on February 09, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00138528
Study ID Number: CXUO320BDE30
ClinicalTrials.gov Identifier: NCT00138528
Health Authority: Germany: Federal Institute for Drugs and Medical Devices
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00138528
